Compare Smith & Nephew plc (SNN) vs Teradata Corporation Common Stock (TDC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Smith & Nephew plc vs Teradata Corporation Common Stock — how do they compare? Smith & Nephew plc trades at $28.24 (market cap $11.60B), while Teradata Corporation Common Stock trades at $29.6 (market cap $2.83B). The key difference: Smith & Nephew plc is far larger — about 4.1× Teradata Corporation Common Stock's market cap, and Smith & Nephew plc pays a 2.85% dividend while Teradata Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Smith & Nephew plc for 121 Days and Teradata Corporation Common Stock for 0 Days on average.
| SNN | TDC | |
|---|---|---|
Market Cap | $11.60B | $2.83B |
Volume | 971,836 | 1,343,944 |
Sector | Health | Technology |
52-Week High | $37.17 | $37.88 |
52-Week Low | $26.42 | $20.71 |
Typical Hold Time | 121 Days | 0 Days |
Enterprise Value | $14.63B | $2.52B |
Dividend Yield | 2.85% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SNN trades at $27.86, near a 52-week low, with a mixed technical signal. Revenue has grown from $5.2B in 2022 to $6.16B in 2025, with net income margin improving to 10.08%. Recent product launches like the EVOS PELVIC System highlight innovation, but the stock faces headwinds from analyst downgrades and CFO departure news.
The outlook is cautious; while fundamentals show steady growth and a reasonable P/E of 18.95, weak sentiment and technical pressure near lows suggest limited near-term upside. Risks include execution challenges and competitive threats, but long-term investors may find value if operational improvements materialize.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →About Teradata Corporation Common Stock
Teradata Corporation develops a hybrid cloud analytics and data platform, including its Teradata Vantage and VantageCloud products, that helps enterprises manage and analyze data across cloud, on-premises, and hybrid environments. It serves industries including retail, financial services, healthcare, and manufacturing.
Read more on TDC →
